Clinical Trials Browser

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04713371 2024-05-09

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Phase 2 Active not recruiting

32 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT03861403 2023-11-30

A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors

Phase 1 Terminated

10 enrolled

BreastGenitourinaryGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence

NCT01343043 2021-06-30

NY-ESO-1

Phase 1 Completed

50 enrolled 17 charts

Sarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma

NCT02234921 2018-10-11

DRibble

Phase 1 Completed

3 enrolled

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

NCT01304797 2017-01-06

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

Phase 1 Unknown

75 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00753220 2014-11-04

CRITICAL

Phase 1/2 Terminated

7 enrolled 4 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Clinical Trials

DUAL-NK-PDAC

BRIA-ABC

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors